82 results
6-K
EX-99.1
ALVO
Alvotech
21 May 24
Current report (foreign)
9:00am
be deemed part of this press release.
IMPORTANT SAFETY INFORMATION FOR SIMLANDI (adalimumab-ryvk) injection
INDICATIONS
SIMLANDI® (adalimumab-ryvk … , posterior, and panuveitis in adult patients.
IMPORTANT SAFETY INFORMATION
WARNING: SERIOUS INFECTIONS and MALIGNANCY
SERIOUS INFECTIONS
Patients
6-K
EX-99.1
ALVO
Alvotech
21 May 24
Current report (foreign)
8:41am
, safety, and tolerability of AVT03 compared to Prolia® in healthy adult subjects [3]. A confirmatory efficacy and safety study for AVT03 in patients
6-K
EX-99.1
ALVO
Alvotech
25 Apr 24
Current report (foreign)
12:36pm
)
The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint … -arm, multicenter confirmatory clinical study to investigate the efficacy, safety, and immunogenicity between subcutaneous AVT05 and EU Simponi
6-K
EX-99.1
ALVO
Alvotech
16 Apr 24
Current report (foreign)
6:30pm
AVT04-GL-301, a randomized, double blind, multicenter, 52-week study to demonstrate equivalent efficacy and to compare safety and immunogenicity between … to Week 12; 2) Study AVT04-GL-101, a Phase I, randomized, double-blind, single-dose, parallel-group, 3-arm study to compare the pharmacokinetic, safety
6-K
EX-99.2
yq3y9nxquo
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
6-K
EX-99.1
dqx2r
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
6-K
EX-99.3
ga1z97t6
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
6-K
EX-99.1
slvu2 h10qg
23 Feb 24
Current report (foreign)
8:39pm
6-K
401ub1a
29 Jan 24
Current report (foreign)
7:00am
6-K
EX-99.1
t32h6
29 Jan 24
Current report (foreign)
7:00am
6-K
EX-99.1
947jiwt6w wv73uj
10 Jan 24
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
7:00am
6-K
EX-99.1
qzsp90ws7jx ae6mx
3 Jan 24
Current report (foreign)
2:28pm
6-K/A
EX-99.1
vv8q6
30 Nov 23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
9:19am
6-K
EX-99.1
imcamd
29 Nov 23
Current report (foreign)
7:00am
6-K
EX-99.1
3sw7 kw9e
29 Nov 23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
7:00am
6-K
EX-99.1
vt4h83r2tdpnh mre
14 Nov 23
Current report (foreign)
4:30pm
6-K
EX-99.1
bceesz7fx3 u31x
13 Nov 23
STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
6:15am
6-K
EX-99.2
1il suj88det
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.4
y5263n6s081mjzhej4
12 Jul 23
This Termination Agreement (“Termination Agreement”) by
12:00am